Crucial role of CD69 in anti-tumor immunity through regulating the exhaustion of tumor-infiltrating T cells
International Immunology · 14.11.2018 · 30 (12) · 559-567
DOI: 10.1093/intimm/dxy050 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunology, online erschienen am 06.08.2018. Verfasst von Yukiyoshi Mita und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Graduate School of Medicine, Chiba University, Chuo-ku, Chiba, Japan. Die Arbeit wurde bisher 87-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Ministry of Education, Culture, Sports, Science and Technology, Challenging Research, Uehara Memorial Foundation.
Abstract (Originalsprache)
The introduction of immune checkpoint inhibitors in cancer treatment highlights the negative regulation of anti-tumor immunity, such as effector T-cell exhaustion in the tumor microenvironment. However, the mechanisms underlying the induction and prevention of T-cell exhaustion remain largely unknown. We found that CD69, a type II glycoprotein known to regulate inflammation through T-cell migration and retention in tissues, plays an important role in inducing the exhaustion of tumor-infiltrating T cells. Cd69–/– mice showed reduced tumor growth and metastasis in a 4T1-luc2 murine breast cancer model, in which increased numbers of tumor-infiltrating lymphocytes, relatively little T-cell exhaustion, and enhanced IFNγ production were observed. Anti-CD69 monoclonal antibody treatment attenuated the T-cell exhaustion and tumor progression in tumor-bearing mice. These findings highlight a novel role of CD69 in controlling the tumor immune escape mediated by T-cell exhaustion and indicate that CD69 is a novel target for cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Immunology, Graduate School of Medicine, Chiba University, Chuo-ku, Chiba, Japan.
- Department of Otorhinolaryngology, Graduate School of Medicine, Chiba University, Chuo-ku, Chiba, Japan.
- Department of Medical Immunology, Graduate School of Medicine, Chiba University, Chuo-ku, Chiba, Japan.
Förderung
- Ministry of Education, Culture, Sports, Science and Technology
- Challenging Research
- Uehara Memorial Foundation
- Astellas Foundation for Research on Metabolic Disorders
- Takeda Science Foundation
Zitieren
APA
Mita, Y., Kimura, M. Y., Hayashizaki, K., Koyama-Nasu, R., Ito, T., Motohashi, S., Okamoto, Y., & Nakayama, T. (2018). Crucial role of CD69 in anti-tumor immunity through regulating the exhaustion of tumor-infiltrating T cells. International Immunology, 30(12), 559-567. https://doi.org/10.1093/intimm/dxy050
Vancouver
Mita Y, Kimura MY, Hayashizaki K, Koyama-Nasu R, Ito T, Motohashi S, et al. Crucial role of CD69 in anti-tumor immunity through regulating the exhaustion of tumor-infiltrating T cells. International Immunology. 2018;30(12):559-567. doi:10.1093/intimm/dxy050
BibTeX
@article{Mita2018,
author = {Mita, Yukiyoshi and Kimura, Motoko Y and Hayashizaki, Koji and Koyama-Nasu, Ryo and Ito, Toshihiro and Motohashi, Shinichiro and Okamoto, Yoshitaka and Nakayama, Toshinori},
title = {Crucial role of CD69 in anti-tumor immunity through regulating the exhaustion of tumor-infiltrating T cells},
journal = {International Immunology},
year = {2018},
volume = {30},
number = {12},
pages = {559--567},
doi = {10.1093/intimm/dxy050}
}
EUVIMED